FinTechs and banks unite for innovation at DIFC’s Dubai FinTech Summit Dialogues
DIFC-led dialogue hosts ten heads of banks and FinTechs for discussion on current financial stability…
Month: April 2023
SugarCRM Named a Leader in the Nucleus Research CRM Value Matrix for Third Year Running
SAN FRANCISCO–(BUSINESS WIRE)–SugarCRM, provider of the award-winning AI-driven CRM platform, today announced it has been…
SANBlaze Releases OCP Testing and Major Updates to NVMe Test Suite
Comprehensive Upgrades Include OCP 1.0a Scripts and Low Power Sub-States Validation in Latest Version 10.5…
Sevco Security Expands Leadership Team with Appointment of Brian Contos as Chief Strategy Officer
Former ArcSight, Imperva, and Verodin Security Leader Brings More Than 25 Years of Experience to…
DataCore Introduces Perifery Division for High-Growth Edge Markets
Perifery Offers Groundbreaking Edge Solutions for Companies in Media and Entertainment FT. LAUDERDALE, Fla.–(BUSINESS WIRE)–DataCore…
ReadyLinks joins HomeGrid Forum, bringing cloud-managed networking knowledge for accelerating G.hn Access deployments
Beaverton, April 11, 2023: Industry-leading cloud networking specialists, ReadyLinks, have joined the HomeGrid Forum. They…
Belite Bio to Host Key Opinion Leader Webinar on RBP4 Antagonist Tinlarebant in Late-Stage Development for Stargardt Disease 1
Virtual event on Wednesday, May 3rd at 1:00 PM ET will feature key opinion leader…
Belite Bio to Host Key Opinion Leader Webinar on RBP4 Antagonist Tinlarebant in Late-Stage Development for Stargardt Disease 1
Virtual event on Wednesday, May 3rd at 1:00 PM ET will feature key opinion leader…
AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
Leading Diagnostic Healthcare Company Begins Manufacturing of Ocular Immunoglobulin (IgE), Lactoferrin Tests to Fulfill Orders…
AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
Leading Diagnostic Healthcare Company Begins Manufacturing of Ocular Immunoglobulin (IgE), Lactoferrin Tests to Fulfill Orders…
Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses
Sabizabulin inhibited the cell release and cell-to-cell spread of poxvirus in a preclinical study Veru…
Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses
Sabizabulin inhibited the cell release and cell-to-cell spread of poxvirus in a preclinical study Veru…
Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium
Dr. Redkar to discuss importance of HGF/cMET pathway, which can play critical role in origin…
Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium
Dr. Redkar to discuss importance of HGF/cMET pathway, which can play critical role in origin…
Inozyme Pharma to Participate at the 22nd Annual Needham Virtual Healthcare Conference
BOSTON, April 11, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical- stage…
Inozyme Pharma to Participate at the 22nd Annual Needham Virtual Healthcare Conference
BOSTON, April 11, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical- stage…
Prelude Therapeutics to Present at American Association for Cancer Research 2023 Conference
Eight Abstracts Demonstrate Progress of Prelude’s Differentiated Pipeline WILMINGTON, Del., April 11, 2023 (GLOBE NEWSWIRE)…
Prelude Therapeutics to Present at American Association for Cancer Research 2023 Conference
Eight Abstracts Demonstrate Progress of Prelude’s Differentiated Pipeline WILMINGTON, Del., April 11, 2023 (GLOBE NEWSWIRE)…
Panbela Regains Worldwide Rights to Develop and Commercialize FlynpoviTM in Patients with Familial Adenomatous Polyposis (FAP)
MINNEAPOLIS, April 11, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Panbela Regains Worldwide Rights to Develop and Commercialize FlynpoviTM in Patients with Familial Adenomatous Polyposis (FAP)
MINNEAPOLIS, April 11, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…